Updated:
Viatris Inc.
Viatris Inc. is a publicly traded global healthcare company headquartered in Canonsburg, Pennsylvania, focused on accessible medicines and supply...
Viatris Inc.
Viatris Inc. is a publicly traded global healthcare company, not a family office. Founded in 2020 through the merger of Mylan and Upjohn (a Pfizer spin-off), it has its headquarters in Canonsburg, Pennsylvania. Viatris generates revenue through the sale of prescription drugs, generics, and over-the-counter products. Its portfolio includes cardiovascular, central nervous system, and respiratory therapies, among others. The company operates manufacturing and R&D facilities in multiple countries including the United States, India, and Europe. The company employs thousands globally and is listed on the NASDAQ under the ticker VTRS. It does not function as an investment vehicle or wealth manager. In May 2026, Viatris was named to TIME’s World’s Most Impactful Companies list. As a public pharmaceutical company, Viatris is structurally distinct from family offices or asset managers. It is governed by a board of directors accountable to public shareholders, not to a single family or group of principals.
General information
Firm type
other
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Canonsburg
Corporate office
Canonsburg, PA, United States
Sector focus
Frequently asked questions
Is Viatris a family office or an investment firm?
No. Viatris is a publicly traded pharmaceutical company (NASDAQ: VTRS), not a family office. It manufactures and sells prescription drugs, generics, and over-the-counter products.
Who leads Viatris?
Viatris is managed by a CEO and executive team, accountable to its board of directors. The firm's public filings name its leadership, which changes periodically. As of mid-2026, its website does not list a permanent dedicated leadership page.
What is Viatris's business model?
Viatris develops, manufactures, and distributes medicines across a broad range of therapeutic areas. It operates both branded and generic product lines, with a focus on affordability and global supply resilience.
Does Viatris manage assets on behalf of external investors?
No. Viatris does not operate as an asset manager or investment vehicle. Its revenues come from product sales, not from managing third-party capital.
Where is Viatris headquartered?
Viatris's headquarters are in Canonsburg, Pennsylvania, United States. It has additional operational sites and manufacturing facilities globally.
What is Viatris's relationship to Mylan and Pfizer?
Viatris was created in 2020 from the merger of Mylan and Upjohn (a division of Pfizer). Pfizer spun off the Upjohn business to combine with Mylan, forming Viatris.
Is Viatris publicly traded?
Yes. Viatris trades on the NASDAQ under the ticker VTRS. As a public company, its financial disclosures are available via SEC filings.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: